KLF4 suppresses the proliferation and metastasis of NSCLC cells via inhibition of MSI2 and regulation of the JAK/STAT3 signaling pathway

被引:0
|
作者
Luo, Di-Di [1 ]
Zhao, Feng [2 ]
机构
[1] Frist Peoples Hosp Xiangtan, Dept Med Oncol, Xiangtan 411101, Hunan, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2022年 / 22卷
关键词
Kruppel-like factor 4; MSI2; JAK2/STAT3; NSCLC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-small cell lung cancer (NSCLC) remains an aggresive tumor with poor survival rates. Kruppellike factor 4 (KLF4) is known to be involved in progression of NSCLC; however, the detailed mechanism by which KLF4 regulates the progression of NSCLC remains unclear. Methods: In order to investigate the function of KLF4 in NSCLC, cell proliferation was measured by MTT and colony formation assays. The migration and invasion of NSCLC cells were detected via wound healing and Transwell assays, respectively. Then, the interaction between KLF4 and MSI2 was confirmed using a dualluciferase reporter assay, and the mechanism by which KLF4 regulates the tumorigenesis of NSCLC was assessed by RT-qPCR and Western blotting. Results: The results showed that KLF4 was downregulated, while MSI2 was upregulated in NSCLC. Additionally, KLF4 could inhibit transcription of MSI2, and overexpression of KLF4 or knockdown of MSI2 could inhibit the proliferation, migration and invasion of NSCLC cells. Moreover, KLF4 could inhibit JAK2/STAT3 signalling pathway. Conclusions: In conclusion, KLF4 significantly inhibited the proliferation, invasion and migration of NSCLC cells via inactivation of MSI2/JAK2/STAT3 signalling pathway. Thereby, our finding might shed new lights on exploring the new strategies against NSCLC.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Resveratrol attenuates myocardial injury in septic rats via inhibition of the JAK2/STAT3 signaling pathway
    Ji, Zhiyong
    Li, Yubo
    Sun, Guoqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1724 - 1731
  • [42] Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling
    Nanmu Yang
    Feng Han
    Hong Cui
    Jinxi Huang
    Tao Wang
    Yi Zhou
    Jinxue Zhou
    Pharmacological Reports, 2015, 67 : 388 - 393
  • [43] Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC
    Chou, Jou-Chun
    Lieu, Fu-Kong
    Ho, Donald Ming-Tak
    Shen, Heng-Yi
    Lin, Po-Han
    Hu, Sindy
    Wang, Shyi-Wu
    Lin, Ho
    Wang, Paulus S.
    CHEMOSPHERE, 2021, 264
  • [44] Lupus Susceptibility Gene Pbx1 Regulates STAT3 in T cells via JAK2/STAT3 Signaling Pathway
    Roach, Tracoyia A.
    Choi, Seung-Chul
    Park, Yuk Pheel
    Morel, Laurence
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [45] TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway
    Cheng, Shaohua
    Huang, Xinghan
    Guo, Weichun
    JOURNAL OF BONE ONCOLOGY, 2022, 37
  • [46] Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70
    Xu, Neng-Wen
    Chen, Yu
    Liu, Wei'e
    Chen, Yan-Jie
    Fan, Zhi-Min
    Liu, Min
    Li, Lin-Jie
    MEDICAL SCIENCE MONITOR, 2018, 24 : 6255 - 6263
  • [47] Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway
    Ma, Xinglong
    Xu, Wenyuan
    Jin, Xinmeng
    Mu, Haoran
    Wang, Zhuoying
    Hua, Yingqi
    Cai, Zhengdong
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 942
  • [48] Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
    Yang, Yufei
    Cao, Yue
    Chen, Lihua
    Liu, Fei
    Qi, Zihao
    Cheng, Xi
    Wang, Ziliang
    CANCER MEDICINE, 2018, 7 (09): : 4610 - 4618
  • [49] Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3/STAT3 signaling
    Kim, Byung Hak
    Min, Yun Sook
    Choi, Jung Sook
    Baeg, Gyeong-Hun
    Kim, Youngsoo
    Shin, Jong Wook
    Kim, Tae-Yoon
    Ye, Sang-Kyu
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2011, 43 (05): : 313 - 321
  • [50] Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3/STAT3 signaling
    Byung Hak Kim
    Yun Sook Min
    Jung Sook Choi
    Gyeong-Hun Baeg
    Youngsoo Kim
    Jong Wook Shin
    Tae-Yoon Kim
    Sang-Kyu Ye
    Experimental & Molecular Medicine, 2011, 43 : 313 - 321